[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619334":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":33,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":51,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Philippe Schultz, MD, PhD","CONTACT","33 3 88 12 76 36","philippe.schultz@chru-strasbourg.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France","RECRUITING","Strasbourg","67091","France",{"type":22,"coordinates":23},"Point",[24,25],7.74553,48.58392,{"lat":25,"lon":24},[28,29,31],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":10,"role":30,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":32,"role":30,"phone":7,"phoneExt":7,"email":7},"Thibault DEDIEU, MD",{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619334",false,"NCT07343271","Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx","DECT-CEco","Inclusion Criteria:\n\n* Adult patient (≥18 years)\n* presenting with oral or oropharyngeal squamous cell carcinoma proven by histopathological analysis of a biopsy\n* having undergone a clinical examination with nasofibroscopy by an ENT surgeon specializing in cancer surgery\n* a contrast-enhanced cervicofacial MRI\n* and a contrast-enhanced cervicofacial DECT with BOLT maneuver.\n\nExclusion Criteria:\n\n* A lesion other than oral or oropharyngeal squamous cell carcinoma\n* A labial location\n* A contraindication to performing one or both of the imaging examinations.","ALL","18 Years",{"count":44,"type":45},30,"ESTIMATED","OBSERVATIONAL","The diagnostic and pre-therapeutic assessment of squamous cell carcinomas requires a neck and chest CT scan and a neck and facial MRI, which is the most effective examination, to establish the TNM stage of the tumor. However, obtaining this complete assessment can delay treatment. Confirmation of the non-inferiority of 40keV dual-energy CT in BOLT compared to MRI would spare the patient an additional MRI examination, speed up the pre-treatment assessment, reduce the loss of opportunity due to delayed treatment, and free up MRI imaging slots, which are still insufficient in the region.",[49,50],"Oral Squamous Cell Carcinoma","Oropharyngeal Squamous Cell Carcinoma",[49,50,52],"TNM stage of the tumor","2026-01-06",{"date":55,"type":56},"2026-01-15","ACTUAL",{"date":58,"type":56},"2025-07-11",{"date":60,"type":45},"2026-07-11",{"name":5,"class":6},1]